NFE2L2 and non-small cell lung carcinoma: Supportingly, Mitsuishi et al. found that silencing the PPP enzymes G6PD or TKT reduced tumor growth in a KEAP1 mutant NSCLC xenograft model in a similar manner to silencing NRF2 [25].